• Tue, January 5, 2021
• Wed, January 6, 2021
Do Kim Initiated (ABCL) at Buy and Held Target at $48 on, Jan 5th, 2021
Do Kim of BMO Capital, Initiated "AbCellera Biologics Inc." (ABCL) at Buy and Held Target at $48 on, Jan 5th, 2021.
Do, nor any peers, have made any analyst calls on ABCL in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
WOPRAI
Market Predictions Driven by AI
- Website: https://www.woprai.com/
- Email: support@woprai.com